Lexicon Pharmaceuticals Inc
LXRX
Market Cap$254.59M
Close$
$-0.39
155.9% downside
Current Fair Value
155.9% downsideOvervalued by 155.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $254.59 Million |
|---|---|
| Enterprise Value | $296.33 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.63 |
| Beta | 1.08 |
| Outstanding Shares | 361,492,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.26 |
|---|---|
| PEG | -4.47 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 56.77 |
| Enterprise Value to EBIT | -1.4 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
ESG Score
No data